Review

Cardiovascular Risk in Psoriatic Arthritis in the Treat-to-Target Era: A Focused Expert Narrative Review of Epidemiology, Risk Assessment, Vascular Imaging, and Prevention

Figure 1. Focused evidence map for cardiovascular risk in psoriatic arthritis.
Open the figure at full size
Figure 1. Focused evidence map for cardiovascular risk in psoriatic arthritis.Focused evidence map for cardiovascular risk in psoriatic arthritis.Avram et al. · CC BY

Journal of Clinical Medicine

Abstract

Background/Objectives: Psoriatic arthritis (PsA) is associated with excess cardiovascular (CV) morbidity, but the supporting literature spans heterogeneous observational, imaging, prediction, therapeutic, and guideline sources.

The paper

Victor Babeș University of Medicine and Pharmacy Timișoara

Journal of Clinical Medicine · 19 Sep 2026 · CC BY

doi.org/10.3390/jcm15187283PubMed 42796055